Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 14, 2023
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
Andrew Fein Reiterated (TCRX) at Strong Buy and Held Target at $15 on, Aug 14th, 2023
Andrew Fein of HC Wainwright & Co., Reiterated "TScan Therapeutics, Inc." (TCRX) at Strong Buy and Held Target at $15 on, Aug 14th, 2023.
Andrew has made no other calls on TCRX in the last 4 months.
There is 1 other peer that has a rating on TCRX. Out of the 1 peers that are also analyzing TCRX, 0 agree with Andrew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Andrew
- David Nierengarten of "Wedbush" Initiated at Buy and Held Target at $8 on, Thursday, June 22nd, 2023
